| Receive this email from someone else? Subscribe now! By: Theresa M. Mullin, Ph.D. Sometimes, the most valuable thing we can do as regulators at FDA is simply to listen. I’m reminded of that each time we hold a public meeting as part of the Patient-Focused Drug Development (PFDD) … Continue reading |
You’re four weeks away from more followers 📱
Here's what we're talking about this week at Teachable ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏...
Comments
Post a Comment